LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

Search

ResMed Inc

Ouvert

SecteurSoins de santé

240.33 -3.61

Résumé

Variation du prix de l'action

24h

Actuel

Min

236.49

Max

249.67

Chiffres clés

By Trading Economics

Revenu

44M

393M

Ventes

87M

1.4B

P/E

Moyenne du Secteur

24.993

66.845

Rendement du dividende

0.89

Marge bénéficiaire

27.593

Employés

10,600

EBITDA

63M

566M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+18.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.89%

2.25%

Prochains Résultats

22 avr. 2026

Date du Prochain Dividende

19 mars 2026

Date du Prochain Détachement de Dividende

7 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-371M

37B

Ouverture précédente

243.94

Clôture précédente

240.33

Sentiment de l'Actualité

By Acuity

17%

83%

15 / 351 Classement par Healthcare

ResMed Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 mars 2026, 20:38 UTC

Résultats

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mars 2026, 23:57 UTC

Market Talk

Global Equities Roundup: Market Talk

10 mars 2026, 23:57 UTC

Market Talk

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mars 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mars 2026, 23:37 UTC

Acquisitions, Fusions, Rachats

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mars 2026, 23:35 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mars 2026, 23:06 UTC

Résultats

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mars 2026, 22:51 UTC

Principaux Événements d'Actualité

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mars 2026, 21:21 UTC

Résultats

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mars 2026, 21:15 UTC

Résultats

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mars 2026, 21:15 UTC

Acquisitions, Fusions, Rachats

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mars 2026, 21:14 UTC

Résultats

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mars 2026, 21:13 UTC

Résultats

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q Rev $597.3M >FNV

10 mars 2026, 21:12 UTC

Résultats

Franco-Nevada 4Q EPS $1.90

10 mars 2026, 20:57 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

10 mars 2026, 20:44 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

10 mars 2026, 20:34 UTC

Market Talk
Résultats

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mars 2026, 20:23 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mars 2026, 20:16 UTC

Résultats

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mars 2026, 20:14 UTC

Résultats

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mars 2026, 20:14 UTC

Résultats

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mars 2026, 20:13 UTC

Résultats

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mars 2026, 20:12 UTC

Résultats

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Comparaison

Variation de prix

ResMed Inc prévision

Objectif de Prix

By TipRanks

18.86% hausse

Prévisions sur 12 Mois

Moyen 300.64 USD  18.86%

Haut 345 USD

Bas 265 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

13 ratings

8

Achat

5

Maintien

0

Vente

Sentiment

By Acuity

15 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat